Login

Anti-ITGA4+ITGB7 (Vedolizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC

CAT:
708-ADC-W-2497
Size:
1 mg
Price:
Ask
For price, please contact [email protected]
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Anti-ITGA4+ITGB7 (Vedolizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC - image 1

Anti-ITGA4+ITGB7 (Vedolizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC

  • Description: This ADC product is comprised of an anti-ITGA4+ITGB7 monoclonal antibody conjugated via a MC-Vc-PAB-DMEA-(PEG2) linker to duocarmycin SA. The duocarmycin SA is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, duocarmycin SA binds to DNA, causes DNA damage.
  • CAS Number: 9007-83-4
  • Format: Solution
  • Shipping Conditions: Ice Packs
  • Storage Conditions: -20°C